Tourniquet Systems Market Size & Share 2026-2035

Tourniquet Systems Market Size

The global tourniquet systems market was estimated at USD 549.7 million in 2025. The market is expected to grow from USD 590.2 million in 2026 to USD 1.2 billion in 2035, at a CAGR of 8.2% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market is driven by numerous factors, such as the increasing number of trauma and accident cases and the rising number of joint replacement surgeries, among other factors.

A tourniquet system is a device that applies pressure to restrict the blood flow in an extremity, both arteries and veins, for a specific duration. It is primarily used in emergency situations and surgical procedures to control bleeding effectively.

Rising awareness of blood loss management is expected to fuel the industry's growth. ulrich medical, ZIMMER BIOMET, stryker, Anetic Aid, and Hammarplast Medical AB are among the leading players operating in the market. These players mainly focus on product innovation, geographic expansion, research and development, and collaboration with local or regional healthcare providers, among other factors.

The increasing number of trauma and accident cases has emerged as a key driver for the growth of the tourniquet systems market, as severe injuries frequently require rapid bleeding control in emergency and surgical settings. According to the World Health Organization (WHO), approximately 1.19 million people die annually due to road traffic accidents globally, while an additional 20–50 million individuals sustain non‑fatal injuries, many of which result in long‑term disabilities. Furthermore, road traffic injuries have remained the leading cause of death among individuals aged 5–29 years, with over 90% of fatalities occurring in low‑ and middle‑income countries. The high incidence of traumatic injuries and hemorrhage associated with these accidents has significantly increased the demand for effective bleeding control interventions, thereby driving the adoption of tourniquet systems across emergency medical services, military applications, and hospital trauma care.

Additionally, the increasing prevalence of degenerative bone disorders and musculoskeletal diseases among the adult population has contributed significantly to the growth of the market by driving higher volumes of orthopedic and reconstructive surgical procedures. According to the World Health Organization (WHO) data 2022, approximately 1.71 billion people globally were living with musculoskeletal (MSD) conditions, making them the leading contributor to disability worldwide. The high surgical burden associated with these conditions, particularly in joint replacement and orthopedic interventions, has increased the demand for effective intraoperative blood flow control, thereby supporting the adoption of tourniquet systems across hospital and surgical settings.

Tourniquet Systems Market Trends

• The technological advancements in tourniquet systems are playing a critical role in driving market growth by enhancing surgical precision, patient safety, and procedural efficiency. Modern tourniquet systems are increasingly incorporating automated pressure regulation, limb occlusion pressure (LOP) monitoring, and integrated safety alarms, enabling clinicians to apply optimal pressure levels tailored to individual patient requirements.
• These innovations reduce the risk of complications such as nerve damage, tissue injury, and post‑operative pain, thereby improving clinical outcomes and expanding adoption across orthopedic and surgical procedures. Additionally, the integration of digital interfaces, data tracking, and connectivity features supports better intraoperative monitoring and documentation, aligning with evolving standards for patient safety and value‑based healthcare.
• For instance, the SmartPump Tourniquet System by Stryker integrates automated calibration, real‑time pressure monitoring, and safety validation features to ensure consistent and accurate performance during surgery. Similarly, the A.T.S. 4000 Tourniquet System by ZIMMER BIOMET utilizes personalized pressure technology to deliver patient‑specific pressure settings, minimizing risks associated with excessive tourniquet force. Collectively, product innovations in tourniquet systems emphasize a strong industry focus on precision‑driven, patient‑centric solutions, thereby reinforcing technological advancement as a key factor supporting the sustained growth of the global market.

Tourniquet Systems Market Analysis

Based on component, the tourniquet systems market is segmented into tourniquet instruments and tourniquet cuffs. The tourniquet cuffs segment accounted for a dominant market share of 68% in 2025, driven by their critical role in delivering effective and uniform pressure application during surgical procedures. The segment is expected to reach USD 804 million by 2035, growing at a CAGR of 8% during the forecast period.

• The tourniquet cuffs segment represented the dominating component category in the market, driven by their essential role in directly applying controlled pressure to limbs during surgical procedures. These cuffs are available in various sizes, materials, and configurations, including single and dual bladder designs, to accommodate different surgical requirements and patient anatomies. Continuous innovation in cuff design, including improved pressure distribution, enhanced comfort, and reduced risk of tissue damage, has supported widespread clinical adoption across hospital and surgical settings.
• The tourniquet instruments segment is projected to expand at 8.7% CAGR to reach USD 400.1 million by 2035. The tourniquet instruments segment comprises electronic and pneumatic systems used to regulate and maintain controlled pressure during surgical procedures. These instruments are designed to ensure precise blood flow restriction through automated pressure control, safety monitoring features, and user‑friendly interfaces. Adoption of tourniquet instruments is supported by increasing surgical volumes, advancements in pressure regulation technologies, and the need for enhanced intraoperative control in orthopedic and trauma procedures.

Based on application, the tourniquet systems market is segmented into upper limb and lower limb. The lower limb segment is projected to expand at 8.1% CAGR to reach USD 691.5 million by 2035.

• The lower limb segment represented the dominating application category in the market, reflecting its extensive utilization in procedures such as knee and hip replacements, fracture repairs, and other major orthopedic surgeries. Tourniquet systems are widely used in lower limb applications to facilitate a bloodless surgical field, enhance visibility during complex procedures, and support accurate implant placement. Continuous advancements in pressure control technologies and increasing surgical volumes further supported the adoption of tourniquet systems in this segment.
• The upper limb segment is projected to expand at 8.4% CAGR to reach USD 512.7 million by 2035. The upper limb segment includes the use of tourniquet systems in surgical procedures involving the arms, forearms, and hands. These applications are commonly observed in orthopedic surgeries, trauma interventions, and reconstructive procedures requiring controlled blood flow and improved surgical visibility. Tourniquet systems in upper limb applications support precise pressure regulation, reduced intraoperative blood loss, and enhanced procedural efficiency, contributing to improved surgical outcomes and recovery.

• The hospitals segment represented the dominating end‑use category in the market, reflecting the extensive utilization of tourniquet systems in surgical procedures performed within hospital settings. The presence of advanced operating rooms, high surgical volumes across orthopedic and trauma procedures, and availability of skilled healthcare professionals supported consistent adoption of tourniquet systems. Integration of advanced surgical technologies and focus on improving intraoperative efficiency further reinforced their use in hospital environments.
• The ambulatory surgical centers segment is projected to expand at 8.5% CAGR to reach USD 420.5 million by 2035. The ambulatory surgical centers segment includes the use of tourniquet systems in outpatient surgical procedures that require shorter recovery times and efficient workflows. These centers increasingly adopt tourniquet systems to support minimally invasive orthopedic interventions, improve procedural accuracy, and enhance patient throughput. The shift toward cost‑effective surgical care continues to support adoption within this segment.
• The other end users segment is projected to expand at 7.9% CAGR to reach USD 207.8 million by 2035. The others segment comprises specialty clinics, emergency care units, and military or field medical settings where tourniquet systems are used for both surgical and trauma care applications. Utilization in these settings is driven by the need for rapid hemorrhage control and effective blood flow management in non‑hospital environments. Growing emphasis on emergency preparedness and trauma response capabilities supports the continued use of tourniquet systems across these end users.

 North America Tourniquet Systems Market

The North America market accounted for a majority share of 39.3% in 2025 and is anticipated to show notable growth over the forecast period.

• The U.S. market was valued at USD 163.9 million and USD 175.5 million in 2022 and 2023, respectively. The market size reached USD 202.1 million in 2025, growing from USD 188.8 million in 2024, and is anticipated to grow at a CAGR of 7.6% from 2026 to 2035.
• The North America market was significantly influenced by the high burden of trauma- and injury‑related cases, which continued to drive demand for effective intraoperative blood management solutions. According to the Centers for Disease Control and Prevention (CDC), the number of emergency department visits for unintentional injuries was reported at approximately 26.2 million in 2022, highlighting the substantial volume of trauma cases requiring urgent medical intervention. The increasing frequency of surgical procedures associated with fractures, soft‑tissue injuries, and orthopedic trauma created sustained demand for tourniquet systems, particularly in hospital emergency and surgical settings where rapid bleeding control and a clear surgical field are critical.
• Furthermore, the region’s well‑established healthcare infrastructure, high adoption of advanced surgical technologies, and strong presence of key market players supported the widespread integration of tourniquet systems across clinical workflows. The growing emphasis on improving surgical precision, minimizing operative complications, and enhancing patient outcomes further contributed to product adoption. As a result, North America continued to represent a leading market for tourniquet systems, driven by high procedural volumes, technological innovation, and an increasing focus on efficient trauma care management.

Europe Tourniquet Systems Market

Europe accounted for a significant share of the global market and was valued at USD 156.7 million in 2025.

• The Europe market was supported by the growing volume of trauma‑related clinical interventions linked to accident incidence across the region. According to Eurostat, more than 173,500 deaths were recorded due to accidents in the European Union in 2022, representing approximately 3.4% of total mortality, indicating a sustained burden on emergency and surgical care systems.
• The high incidence of trauma cases continued to drive demand for surgical procedures requiring effective intraoperative blood management, thereby supporting the utilization of tourniquet systems in orthopedic and reconstructive interventions across Europe.

Asia Pacific Tourniquet Systems Market

The Asia Pacific market accounted for a substantial share of the market and was valued at USD 126.5 million in 2025.

• The Asia Pacific market was increasingly influenced by the rising burden of musculoskeletal (MSK) disorders across the region, which significantly expanded the patient population requiring orthopedic and trauma‑related surgical interventions. According to the World Health Organization (WHO), musculoskeletal diseases were reported to affect over 427 million people in high‑income Asia Pacific countries and approximately 369 million individuals in South‑East Asia in 2021. This substantial disease burden increased the prevalence of degenerative bone conditions such as osteoarthritis, spine disorders, and joint degeneration, thereby driving demand for surgical procedures where effective intraoperative blood flow control solutions such as tourniquet systems are essential.
• Additionally, improving healthcare access and the expansion of orthopedic and surgical infrastructure across emerging Asia Pacific economies supported sustained market growth. As the incidence of age‑related musculoskeletal conditions continued to rise, healthcare systems increasingly adopted tourniquet systems to enhance surgical precision, reduce intraoperative blood loss, and improve postoperative recovery outcomes. Combined with rising healthcare expenditure, growing medical tourism in countries such as India and Thailand, and increasing adoption of advanced surgical practices, these factors positioned Asia Pacific as a high‑growth region within the global market.

Latin America Tourniquet Systems Market

The Latin America market is anticipated to exhibit remarkable growth during the analysis period.

• The Latin America market was increasingly influenced by the rising number of joint replacement surgeries across the region, driven by the growing burden of orthopedic conditions and degenerative joint diseases. The increasing incidence of osteoarthritis, trauma‑related injuries, and lifestyle‑associated musculoskeletal disorders contributed to higher volumes of procedures such as knee and hip replacements. This trend significantly increased the demand for intraoperative blood management solutions, where tourniquet systems play a critical role in providing a bloodless surgical field, improving visualization, and enhancing procedural outcomes in orthopedic surgeries.
• Furthermore, improvements in healthcare infrastructure and the gradual expansion of orthopedic surgical capabilities across key countries such as Brazil, Mexico, and Argentina supported market growth. Public and private healthcare providers increasingly invested in advanced surgical technologies to meet the growing demand for joint replacement procedures, particularly among aging and active adult populations. These developments contributed to the increased adoption of tourniquet systems in hospital settings, reinforcing their importance in enhancing surgical efficiency, reducing intraoperative blood loss, and supporting postoperative recovery outcomes across Latin America.

Middle East and Africa Tourniquet Systems Market

The Middle East and Africa market is expected to experience substantial growth over the analysis timeframe.

• The Middle East and Africa (MEA) market was influenced by the growing prevalence of orthopedic conditions and the increasing number of surgical procedures required to manage trauma and degenerative joint disorders across the region. Rising incidence of musculoskeletal diseases, road traffic injuries, and workplace accidents contributed to higher volumes of orthopedic surgeries, particularly in urban healthcare centers. This trend supported the demand for tourniquet systems, which are essential for maintaining controlled blood flow and improving surgical visibility during complex procedures.
• Growth was further supported by expanding healthcare infrastructure and increasing government and private sector investments in advanced surgical care, particularly in countries such as Saudi Arabia, the UAE, and South Africa. The development of multispecialty hospitals, improved access to surgical technologies, and rising adoption of minimally invasive and orthopedic procedures contributed to the steady integration of tourniquet systems in clinical practice. These factors collectively positioned the MEA region as an emerging market with gradual but consistent growth potential in the global market.

Tourniquet Systems Market Share

• The market is highly dynamic, with key players such as ulrich medical, ZIMMER BIOMET, stryker, Anetic Aid, and Hammarplast Medical AB, which collectively account for 45% of the global market.

• Leading medical device manufacturers in the market derive competitive advantage from well‑established relationships with hospitals, surgical centers, and orthopedic networks, supported by comprehensive product portfolios that include advanced tourniquet instruments and cuffs. These companies leverage integrated surgical solutions with features such as automated pressure control, limb occlusion monitoring, and safety‑enhanced systems to support precision in orthopedic and trauma procedures. Their strategic strength lies in delivering reliable intraoperative blood management solutions through standardized equipment, clinician training programs, and optimized operating room workflows, thereby improving surgical efficiency and patient outcomes.
• Concurrently, emerging and regional manufacturers are expanding their market presence by offering cost‑effective and application‑specific tourniquet systems tailored to local healthcare requirements and budget constraints. Innovation within the competitive landscape is focused on advancements in cuff materials, improved pressure distribution technologies, and ergonomic system design aimed at enhancing patient safety and comfort. Strategic collaborations, distribution partnerships, and targeted mergers and acquisitions continue to play a critical role as market participants seek to expand geographic reach, strengthen product offerings, and enhance differentiation within the evolving global market.

Tourniquet Systems Market Companies

A few of the prominent players operating in the global tourniquet systems industry include:

• Anetic Aid               
• ATMOS Medizintechnik                  
• CAT Resources, LLC            
• Delfi             
• DESSILLIONS & DUTRILLAUX                  
• Hammarplast Medical AB               
• OHK Medical Devices          
• REVMED X               
• Rudolf Riester GmbH          
• SAM MEDICAL         
• stryker         
• TACMED Solutions              
• Teleflex Incorporated         
• ulrich medical          
• VBM Medizintechnik GmbH            
• ZIMMER BIOMET                

• ulrich medical

ulrich medical has established a presence in the tourniquet systems market through its focus on surgical support equipment and specialized medical devices used in orthopedic and trauma procedures. The company’s approach emphasizes precision engineering, reliability, and compatibility with modern operating room environments, supporting effective intraoperative blood flow control. Its product portfolio is aligned with evolving surgical practices that demand improved safety, ease of use, and integration with broader surgical workflows.

• ZIMMER BIOMET

ZIMMER BIOMET holds a strong position in the market through its extensive portfolio of advanced pneumatic tourniquet systems, including the A.T.S. series. The company focuses on patient‑specific pressure management technologies, such as Personalized Pressure® and limb occlusion pressure (LOP) monitoring, to enhance surgical precision and reduce postoperative complications. Its established relationships with orthopedic surgeons and hospitals, combined with continuous innovation in operating room solutions, support consistent adoption across high‑volume surgical procedures.

• stryker

stryker is a key participant in the tourniquet systems market, driven by its SmartPump tourniquet system and integrated surgical solutions portfolio. The company emphasizes automation, real‑time pressure regulation, and advanced safety features to optimize intraoperative performance and patient outcomes. Leveraging its strong global distribution network and focus on connected operating room technologies, stryker continues to support efficient surgical workflows and expand its presence in orthopedic and trauma care applications.

Tourniquet Systems Industry News

• In November 2025, Delfi Medical expanded its collaborative ecosystem through its partnership with Owens Recovery Science, focusing on the integration of its Personalized Tourniquet System (PTS) in rehabilitation and surgical applications. The collaboration supported clinician training, standardized protocols, and broader adoption of controlled blood flow technology, thereby enhancing patient outcomes and ensuring safe tourniquet pressure application.
• In June 2024, Technimount EMS entered into an exclusive distribution agreement with Compression Works in Canada, aimed at expanding the availability of advanced compression and mounting solutions for emergency medical services. The partnership enabled broader market access, strengthened distribution capabilities, and enhanced product availability across Canadian healthcare and emergency response systems, thereby supporting improved patient care and operational efficiency in pre‑hospital and transport settings.

The global tourniquet systems market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Component

• Tourniquet instruments                
• Tourniquet cuffs                
  • Pneumatic     
    • Disposable
    • Reusable
  • Non-pneumatic

Market, By Application

• Upper limb
• Lower limb

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE